
|Articles|October 29, 2021
Daily OTC Pearl: Omeprazole (Prilosec)
Author(s)Saro Arakelians, PharmD
Prilosec treats duodenal ulcer and gastric ulcer in adults, treatment of gastroesophageal reflux disease (GERD) in adults and children, and maintenance of healing of erosive esophagitis.
Advertisement
OTC/Lifestyle Pearl of the Day: Omeprazole (Prilosec)
Indication: Prilosec is a proton pump inhibitor indicated for the treatment of duodenal ulcer and gastric ulcer in adults, treatment of gastroesophageal reflux disease in adults and children, and maintenance of healing of erosive esophagitis.
Insight:
- Dosing: Includes 20mg, 40mg, and 60mg.
- Dosage form: 10 mg, 20 mg and 40 mg. Delayed-release oral suspension 2.5 mg or 10 mg.
- Adverse events (AEs): Most common AEs in adults (incidence ≥ 2%) are headache, abdominal pain, nausea, diarrhea, vomiting, and flatulence.
- Mechanism of action: Omeprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that suppress gastric acid secretion by specific inhibition of the H+ /K+ ATPase enzyme system at the secretory surface of the gastric parietal cell.
- Manufacturer: AstraZeneca
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
GoodRx Expands Access to Oral GLP-1 Therapy With Semaglutide Pill Cash Pricing
2
Federal Health Officials Scale Back Number of Recommended Vaccines for Children
3
Beyond Injections: Orforglipron and the Future of Oral GLP-1 Receptor Agonist Therapy
4
Former FDA Chief Scientist Jesse Goodman Breaks Down the Implications of Pediatric Vaccine Guideline Changes
5












































































































































































































